The Scleroderma Research Foundation is continually looking for opportunities to increase understanding of scleroderma pathogenesis and to promote the design and development of innovative therapeutic approaches. We encourage applications from current scleroderma specialists as well as from those who have not previously worked on scleroderma.

Research grant applications for the following grants are considered:

• Investigator-initiated Research Grant (up to three years and an annual maximum award of $200,0000)
• Exploratory/Developmental Research Grant (up to two years and an annual maximum award of $75,000)
• New Faculty Grant (up to two years and an annual maximum award of $75,000)
• Postdoctoral Fellowship Grant (up to two years and an annual maximum award of $55,000)

The specific number of projects to be funded will depend on the merit and scope of the applications received and the availability of funds.

Funding support from the SRF may NOT be used for administrative overhead, indirect expenses, or other institutional charges. The sole exception to this prohibition is that the SRF will pay indirect costs of up to 7.5% of the direct project costs for multi-center (including more than 10 distinct clinical centers), longitudinal patient studies (with an agreement for at least 3 years of follow-up) that are intended to enroll more than 1,000 scleroderma patients.

Grant application details for the 2021 funding cycle will be available in October 2020. For other questions, please contact Joanne Gold: joanne@sclerodermaresearch.org